How to train a mouse-methodological issues in pre-clinical exercise oncology.
Exercise oncology
dose-response
human relevance
rodent models
translational research
Journal
American journal of cancer research
ISSN: 2156-6976
Titre abrégé: Am J Cancer Res
Pays: United States
ID NLM: 101549944
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
05
2019
accepted:
18
05
2019
entrez:
10
7
2019
pubmed:
10
7
2019
medline:
10
7
2019
Statut:
epublish
Résumé
We point at several challenges that current exercise oncology rodent models face, which call their human-relevance into question: the vast majority of pre-clinical studies in exercise oncology treat "physical exercise" as a primitive concept without further analysis or qualification, and their results are based on dosages that no human can endure. The lack of analysis and qualification together with the dosage mismatch conceal the fact that rodents do not run like humans. Consequently, while these pre-clinical studies may yield insights into potential biological mechanisms underlying the systemic effects of physical exercise on cancer, the applicability of this knowledge to preventive interventions in healthy humans and the ability to translate it to practical therapies in the critically ill remain limited. We propose an alternative exercise rodent model that has better chances of meeting these challenges.
Types de publication
Journal Article
Langues
eng
Pagination
1246-1253Déclaration de conflit d'intérêts
None.
Références
N Engl J Med. 1999 Aug 26;341(9):650-8
pubmed: 10460816
Br J Cancer. 2000 Feb;82(3):726-30
pubmed: 10682689
Obes Res. 2002 May;10(5):412-5
pubmed: 12006642
Circulation. 2003 Apr 15;107(14):1858-63
pubmed: 12665486
J Appl Physiol (1985). 2004 Jun;96(6):2249-56
pubmed: 15020578
Life Sci. 2005 Mar 25;76(19):2147-58
pubmed: 15733930
Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):798-804
pubmed: 17001221
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2321-30
pubmed: 18006921
PLoS One. 2009;4(1):e4331
pubmed: 19180229
Colorectal Dis. 2009 Sep;11(7):689-701
pubmed: 19207713
Physiol Behav. 2009 Jun 22;97(3-4):385-93
pubmed: 19303031
Neurobiol Dis. 2009 Sep;35(3):426-32
pubmed: 19524672
Int J Cancer. 2010 Jun 15;126(12):2957-68
pubmed: 19856317
Semin Oncol. 2010 Jun;37(3):297-302
pubmed: 20709211
Recent Results Cancer Res. 2011;186:101-33
pubmed: 21113762
Cancer Prev Res (Phila). 2011 Apr;4(4):502-11
pubmed: 21464030
Health Rep. 2011 Mar;22(1):7-14
pubmed: 21510585
Eur Urol. 2011 Nov;60(5):1029-44
pubmed: 21802197
J Vis Exp. 2012 Jan 29;(59):e3638
pubmed: 22314943
Acta Oncol. 2013 Feb;52(2):195-215
pubmed: 23244677
Compr Physiol. 2012 Oct;2(4):2775-809
pubmed: 23720265
J Neuroinflammation. 2013 Sep 18;10:114
pubmed: 24044641
PLoS One. 2013 Dec 11;8(12):e81459
pubmed: 24349072
Proc Biol Sci. 2014 Jul 7;281(1786):null
pubmed: 24850923
J Am Coll Cardiol. 2014 Aug 5;64(5):472-81
pubmed: 25082581
Eur J Prev Cardiol. 2016 Jan;23(1):14-20
pubmed: 25404752
JAMA Intern Med. 2015 Jun;175(6):970-7
pubmed: 25844882
Breast Cancer (Dove Med Press). 2015 Oct 21;7:353-62
pubmed: 26543382
Curr Protoc Mouse Biol. 2015 Dec 02;5(4):283-290
pubmed: 26629772
Bonekey Rep. 2015 Dec 23;4:768
pubmed: 26788286
JAMA Intern Med. 2016 Jun 1;176(6):816-25
pubmed: 27183032
Cancer Res. 2016 Jul 15;76(14):4032-50
pubmed: 27381680
FASEB J. 2016 Nov;30(11):3745-3758
pubmed: 27458245
JAMA Intern Med. 2017 Mar 1;177(3):335-342
pubmed: 28097313
Cell Metab. 2017 Mar 7;25(3):581-592
pubmed: 28273480
Prog Cardiovasc Dis. 2017 Jun - Jul;60(1):67-77
pubmed: 28385556
Exerc Sport Sci Rev. 2018 Jan;46(1):56-64
pubmed: 29166299
Breast J. 2018 Sep;24(5):849-851
pubmed: 29517166
BMC Cancer. 2019 Jun 4;19(1):536
pubmed: 31164094
Br J Cancer. 1985 Dec;52(6):885-91
pubmed: 4074640
Physiol Behav. 1995 Dec;58(6):1085-9
pubmed: 8623006